Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021151
Filing Date
2020-08-10
Accepted
2020-08-10 16:02:17
Documents
52
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_cormedixinc.htm   iXBRL 10-Q 967832
2 CERTIFICATION f10q0620ex31-1_cormedixinc.htm EX-31.1 11221
3 CERTIFICATION f10q0620ex31-2_cormedixinc.htm EX-31.2 10643
4 CERTIFICATION f10q0620ex32-1_cormedixinc.htm EX-32.1 3624
5 CERTIFICATION f10q0620ex32-2_cormedixinc.htm EX-32.2 3661
  Complete submission text file 0001213900-20-021151.txt   4954300

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20200630.xsd EX-101.SCH 41033
7 XBRL CALCULATION FILE crmd-20200630_cal.xml EX-101.CAL 39771
8 XBRL DEFINITION FILE crmd-20200630_def.xml EX-101.DEF 218509
9 XBRL LABEL FILE crmd-20200630_lab.xml EX-101.LAB 428110
10 XBRL PRESENTATION FILE crmd-20200630_pre.xml EX-101.PRE 229407
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0620_cormedixinc_htm.xml XML 733356
Mailing Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922
Business Address 400 CONNELL DRIVE SUITE 5000 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 201089263
SIC: 2834 Pharmaceutical Preparations